Latest Asx News

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Magnum Mining has advanced its auger drilling campaign at the Piracanjuba North Target, completing 161 holes over 7.4 km² and preparing for key Exploration Target and JORC Resource milestones later this year.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.

ASF Group has divested its non-core coking coal subsidiary for A$3.08 million, aiming to refocus capital towards growth and working capital enhancement.

Strata Minerals has secured a binding agreement with BML Ventures to fund and manage mining at its Zelica Gold Project, paving a capital-light path to production and profit sharing.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.

European Resources has identified six fresh passive seismic anomalies outside prior survey bounds at its Korsnäs rare earth project, prompting an exploration area increase and ongoing survey phases.

Bounty Oil & Gas NL has locked in A$4.5 million from a heavily oversubscribed share placement, with proceeds earmarked for drilling, facility upgrades, and exploration across its Australian assets.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

ARC Funds Limited has secured $600,000 through a share placement priced at a 33% premium to its last traded price, aiming to strengthen its working capital and support growth initiatives.